These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
|
|
Nevada
|
|
23-3023677
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(IRS Employer
Identification No.)
|
|
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
|
|
||||
|
Non-accelerated filer
|
|
☐
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
☒
|
|
|
Emerging Growth
Company |
☐ | ||||||
|
|
|
|
|
|
Page
|
|
|
PART I
|
|
|
|
|
|
Item 1.
|
|
4
|
|
|
|
Item 1A.
|
|
24
|
|
|
|
Item 1B.
|
|
24
|
|
|
|
Item 2.
|
|
24
|
|
|
|
Item 3.
|
|
24
|
|
|
|
Item 4.
|
|
24
|
|
|
|
|
|
|
||
|
PART II
|
|
|
|
|
|
Item 5.
|
|
25
|
|
|
|
Item 6.
|
|
26
|
|
|
|
Item 7.
|
|
27
|
|
|
|
Item 7A.
|
|
38
|
|
|
|
Item 8.
|
|
38
|
|
|
|
Item 9.
|
|
39
|
|
|
|
Item 9A.
|
|
39
|
|
|
|
Item 9B.
|
|
40
|
|
|
|
|
|
|
||
|
PART III
|
|
|
|
|
|
Item 10.
|
|
40
|
|
|
|
Item 11.
|
|
40
|
|
|
|
Item 12.
|
|
40
|
|
|
|
Item 13.
|
|
40
|
|
|
|
Item 14.
|
|
40
|
|
|
|
|
|
|
||
|
PART IV
|
|
|
|
|
|
Item 15.
|
|
40
|
|
|
|
Item 16.
|
41 | |||
| • |
Coding & printing technology (Track and Trace)
|
| • |
RFID
|
| • |
Hologram
|
| • |
Security labels
|
| • |
Packaging design
|
| • |
Others (digital mass sterilization, digital mass encryption, and surveillance technologies)
|
| • |
Coding
|
| • |
Printing technology (Identifiers)
|
| • |
Radio Frequency Identification (“RFID”)
|
| • |
Hologram
|
| • |
Security labels
|
| • |
Packaging design
|
| • |
Others (digital mass sterilization, digital mass encryption, and surveillance technologies)
|
| • |
Passports;
|
| • |
Permanent resident, or “green” cards and visas;
|
| • |
Drivers’ Licenses;
|
| • |
Social Security cards;
|
| • |
Military identification cards;
|
| • |
National transportation cards;
|
| • |
Security cards for access to sensitive physical locations; and
|
| • |
other important identity cards, official documents and security-related cards.
|
| · |
RainbowSecure™
|
| · |
SecureLight™
|
| · |
SecureLight+™
|
| · |
Authentication tools
|
| · |
VeriPAS
tm
Global Product Identifier, Track and Trace System
|
| · |
Cryptocurrencies
|
| · |
Blockchain Authentication
|
| · |
Corporate Networks
|
| · |
Digital Drop Box Access
|
| · |
Physical Access
|
| · |
Banking
|
| · |
Financial Transaction Services
|
| · |
Medical
|
| · |
Gaming
|
| · |
Retail
|
| · |
Notary
|
| · |
Digital Wallets
|
| · |
Legal
|
| · |
Government (e-gov services)
|
| · |
Military
|
| · |
Pharmaceutical
|
| · |
Immigration
|
| · |
Entertainment
|
| · |
Social Media
|
| · |
Mobile Payments
|
| · |
Subscription services
|
| · |
Employee Time Systems
|
| · |
Subscription services market, where revenue is commonly lost due to multiple individuals sharing user credentials to access information and services;
|
| · |
Online gaming market, where financial transactions are performed and geo-location is very important to maintaining compliance with state/country regulations;
|
| · |
Financial services market, where there is a large financial risk to identity theft and fraud, including banking, purchases, mobile payments, and digital wallets
|
| · |
Access control market, where the identity of individuals is key to allow access to buildings as well as digital access to data
|
| · |
Social Media Market to identify people versus robots or imposters
|
| • |
Available to be white-labeled and integrated into existing digital platforms;
|
| • |
Non-Stop, audited, monitored, private cloud service;
|
| • |
Three independent, fault tolerant, redundant data centers;
|
| • |
Global load balancing and traffic management;
|
| • |
High level commercial API’s can be integrated in hours; and
|
| • |
Complete audit information, including fresh biometrics.
|
| · |
Pharmaceuticals
|
| · |
Food
|
| · |
Beverages
|
| · |
Luxury goods
|
| · |
Cosmetics
|
| · |
Alcohol
|
| · |
Auto parts
|
| · |
Aviation parts
|
| · |
Any other label/ packaging requirements
|
| · |
Currency
|
| · |
Stock certificates and bonds
|
| · |
Event tickets
|
| · |
Lottery tickets
|
| · |
Passports
|
| · |
ID cards
|
| · |
Driver’s licenses
|
| · |
Visas
|
| · |
Container seals
|
| · |
Pallet security
|
| · |
Uniforms
|
| · |
Weapons
|
| · |
Ammunition
|
| · |
Pharmaceuticals
|
| · |
Apparel/licensed merchandise
|
| · |
Cosmetics and fragrances
|
| · |
Watches and jewelry
|
| · |
Consumer login credentials
|
| · |
Online transaction approval
|
| · |
Credit cards
|
| · |
Bank checks
|
| · |
Financial documents/promissory notes
|
| • |
product performance, features and liability;
|
| • |
price; new laws and regulations;
|
| • |
product innovation and timing of new product introductions;
|
| • |
ability to develop, maintain and protect proprietary products and technologies;
|
| • |
sales and distribution capabilities;
|
| • |
technical support and service;
|
| • |
brand loyalty;
|
| • |
applications support; and
|
| • |
breadth of product line.
|
|
Fiscal Year Ended December 31, 2017
|
High
|
Low
|
||||||
|
Quarter ended March 31, 2017
|
$
|
0.15
|
$
|
0.06
|
||||
|
Quarter ended June 30, 2017
|
$
|
0.12
|
$
|
0.046
|
||||
|
Quarter ended September 30, 2017
|
$
|
0.15
|
$
|
0.035
|
||||
|
Quarter ended December 31, 2017
|
$
|
0.27
|
$
|
0.06
|
||||
|
Fiscal Year Ended December 31, 2016
|
High
|
Low
|
||||||
|
Quarter ended March 31, 2016
|
$
|
2.50
|
$
|
0.435
|
||||
|
Quarter ended June 30, 2016
|
$
|
0.75
|
$
|
0.09
|
||||
|
Quarter ended September 30, 2016
|
$
|
0.44
|
$
|
0.07
|
||||
|
Quarter ended December 31, 2016
|
$
|
0.39
|
$
|
0.10
|
||||
|
(a) |
(b)
|
(c)
|
|
|
Plan category
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
Weighted-average exercise price of outstanding options, warrants and rights
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
|
|
Equity compensation
plans approved by security holders* |
22,013,530
|
$0.11
|
n/a
|
|
Equity compensation
plans not approved by security holders |
0
|
n/a
|
13,050,000
|
|
Total
|
22,013,530
|
$0.11
|
13,050,000
|
| • |
Our failure to generate increasing material revenues;
|
| • |
Cancellation of key contracts;
|
| • |
Regulatory changes including new laws and rules which adversely affect companies in our line of business;
|
| • |
Our public disclosure of the terms of any financing which we consummate in the future;
|
| • |
Our failure to become profitable;
|
| • |
Our failure to raise working capital;
|
| • |
Any acquisitions we may consummate;
|
| • |
Announcements by us or our competitors of significant contracts, new services, acquisitions, commercial relationships, joint ventures or capital commitments;
|
| • |
Changes in our management;
|
| • |
Our failure to meet financial forecasts we or broker-dealers publicly disclose;
|
| • |
The sale of large numbers of shares of common stock which we may register in the future;
|
| • |
Short selling activities; or
|
| • |
Changes in market valuations of similar companies.
|
|
|
|
|
|
|
|
|
|
|
|
Filed or
|
|
|
|
|
|
Incorporated by Reference
|
|
Furnished
|
||||
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
Date
|
|
Number
|
|
Herewith
|
|
3.1(i)
|
|
|
10-Q
|
|
August 19, 2015
|
|
3.1
|
|
||
|
3.2(ii)
|
|
|
8-K
|
|
August 15, 2017
|
|
3.1
|
|
||
|
4.1
|
|
|
8-K
|
|
June 18, 2015
|
|
3.2
|
|
||
|
4.2
|
|
|
8-K
|
|
June 18, 2015
|
|
3.3
|
|
||
|
10.1
|
|
|
10-K
|
|
April 12, 2017
|
|
10.15
|
|
||
|
10.2
|
|
|
10-K
|
|
April 12, 2017
|
|
4.2
|
|
||
|
10.3
|
|
|
8-K
|
|
November 20, 2017
|
|
10.1
|
|
||
|
10.4
|
|
|
8-K
|
|
May 31, 2017
|
|
10.1
|
|
||
|
10.5
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.1
|
|
||
|
10.6
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.2
|
|
||
|
10.7
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.3
|
|
||
|
10.8
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.4
|
|
||
|
10.9
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.5
|
|
||
|
10.10
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.6
|
|
||
|
10.11
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.7
|
|
||
|
10.12
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.8
|
|
||
|
10.13
|
|
|
10-Q
|
|
May 15, 2017
|
|
10.9
|
|
||
|
10.14
|
|
|
8-K
|
|
May 1, 2017
|
|
10.1
|
|
|
|
|
10.15
|
|
|
8-K
|
|
May 1, 2017
|
|
10.2
|
|
|
|
|
10.16
|
|
|
8-K
|
|
February 10, 2016
|
|
10.1
|
|
|
|
|
10.17
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.1
8
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.
19
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.2
0
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.2
1
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.2
2
|
|
|
8-K
|
|
June 18, 2015
|
|
10.6
|
|
|
|
|
10.2
3
|
|
|
8-K
|
|
June 18, 2015
|
|
10.7
|
|
|
|
|
10.2
4
|
|
|
8-K
|
|
April 29, 2016
|
|
10.1
|
|
|
|
|
10.2
5
|
|
|
8-K
|
|
April 29, 2016
|
|
10.2
|
|
|
|
|
10.2
6
|
|
|
8-K
|
|
April 29, 2016
|
|
10.3
|
|
|
|
|
10.2
7
|
|
|
8-K
|
|
May 2, 2016
|
|
10.1
|
|
|
|
|
10.2
8
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.
29
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.3
0
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.3
1
|
|
|
|
|
|
|
|
|
Filed
|
|
|
10.3
2
|
|
|
|
|
|
|
|
|
Filed
|
|
|
16.1
|
|
|
8-K
|
|
December 1, 2017
|
|
16.1
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
|
Filed
|
|
|
31.2
|
|
|
|
|
|
|
|
|
Filed
|
|
|
32.1
|
|
|
|
|
|
|
|
|
Furnished**
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
Filed
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
Filed
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
Filed
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
Filed
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
Filed
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
Filed
|
|
*
|
Management contract or compensatory plan or arrangement.
|
|
**
|
This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
|
|
|
|
|
|
|
|
VerifyMe, Inc.
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Patrick White
|
|
|
|
|
Patrick White
Chief Executive Officer
|
|
|
|
|
Date: April 16, 2018
|
|
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Patrick White
|
|
Chief Executive Officer
|
|
April 16, 2018
|
|
Patrick White
|
|
(
Principal Executive Officer
)
|
|
|
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ James S. Cardwell
|
|
Chief Financial Officer
|
|
April 16, 2018
|
|
James S. Cardwell
|
|
(
Principal Financial Accounting
Officer ) |
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Norman Gardner
|
Chairman of the Board
|
|
April 16, 2018
|
|
|
Norman Gardner
|
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Carl Berg
|
|
Director
|
|
April 16, 2018
|
|
Carl Berg
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Lawrence Schafran
|
|
Director
|
|
April 16, 2018
|
|
Lawrence Schafran
|
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/Laurence Blickman
|
Director
|
|
April 16, 2018
|
|
|
Laurence Blickman
|
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Howard Goldberg
|
|
Director
|
|
April 16, 2018
|
|
Howard Goldberg
|
|
|
|
|
|
|
PAGE
|
|
|
|
|
|
|
|
|
F-1
|
|
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
|
|
|
|
|
F-3
|
|
|
|
|
|
|
|
|
|
F-4
|
|
|
|
|
|
|
|
|
|
F-5
|
|
|
|
|
|
|
|
|
|
F-6 to F-28
|
|
|
Year Ended
|
||||||||
|
December 31, 2017
|
December 31, 2016
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
693,001
|
$
|
22,644
|
||||
|
Prepaid expenses and other current assets
|
18,668
|
9,425
|
||||||
|
Inventory
|
-
|
17,093
|
||||||
|
TOTAL CURRENT ASSETS
|
711,669
|
49,162
|
||||||
|
OTHER ASSETS
|
||||||||
|
Patents and Trademarks, net of accumulated amortization of
|
||||||||
|
$237,331 and $194,236 as of December 31, 2017 and December 31, 2016
|
191,507
|
231,952
|
||||||
|
TOTAL ASSETS
|
$
|
903,176
|
$
|
281,114
|
||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
$
|
923,202
|
$
|
867,436
|
||||
|
Notes payable net of discount of $0 and $60,931, as of December 31, 2017 and December 31, 2016
|
50,000
|
68,069
|
||||||
|
Common stock payable
– related party
|
122,478
|
|||||||
|
Embedded derivative liability
|
-
|
228,718
|
||||||
|
Warrant liability
|
-
|
394,744
|
||||||
|
TOTAL CURRENT LIABILITIES
|
1,095,680
|
1,558,967
|
||||||
|
STOCKHOLDERS' DEFICIT
|
||||||||
|
Series A Convertible Preferred Stock, $.001 par value, 37,564,767 shares
|
||||||||
|
authorized; 324,778 shares issued and outstanding as of December 31, 2017 and
|
||||||||
|
397,778 shares issued and outstanding as of December 31, 2016
|
325
|
398
|
||||||
|
Series B Convertible Preferred Stock, $.001 par value; 85 shares
|
||||||||
|
authorized; 0.92 shares issued and outstanding as of December 31, 2017 and
|
||||||||
|
December 31, 2016
|
-
|
-
|
||||||
|
Series C Convertible Preferred Stock, $.001 par value; 7,500,000 shares
|
||||||||
|
authorized, 0 shares issued and outstanding as of December 31, 2017 and
|
||||||||
|
1,912,500 issued and outstanding as of December 31, 2016
|
-
|
1,913
|
||||||
|
Series D Convertible Preferred Stock, $.001 par value; 6,000,000
|
||||||||
|
shares authorized; 0 shares issued and outstanding as of December 31, 2017
|
||||||||
|
and 166,750 issued and outstanding as of December 31, 2016
|
-
|
167
|
||||||
|
Common stock of $.001 par value; 675,000,000 authorized; 53,873,872 and 8,681,236
issued, 53,523,332 and 8,330,696 shares outstanding as of December 31, 2017 and
December 31, 2016
|
53,522
|
8,331
|
||||||
|
Additional paid in capital
|
56,198,126
|
40,469,272
|
||||||
|
|
||||||||
|
Treasury stock at cost (350,540 shares at December 31, 2017 and December 31, 2016)
|
(113,389
|
)
|
(113,389
|
)
|
||||
|
Accumulated deficit
|
(56,331,088
|
)
|
(41,644,545
|
)
|
||||
|
STOCKHOLDERS' DEFICIT
|
(192,504
|
)
|
(1,277,853
|
)
|
||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
|
$
|
903,176
|
$
|
281,114
|
||||
|
|
Year Ended
|
|||||||
|
|
December 31, 2017
|
December 31, 2016
|
||||||
|
|
||||||||
|
|
||||||||
|
NET REVENUE
|
||||||||
|
Sales
|
$
|
-
|
$
|
37,055
|
||||
|
TOTAL NET REVENUE
|
-
|
37,055
|
||||||
|
|
||||||||
|
COST OF SALES
|
-
|
24,363
|
||||||
|
|
||||||||
|
GROSS PROFIT
|
-
|
12,692
|
||||||
|
|
||||||||
|
OPERATING EXPENSES
|
||||||||
|
General and administrative (a)
|
1,689,883
|
1,010,648
|
||||||
|
Legal and accounting
|
246,520
|
414,032
|
||||||
|
Payroll expenses (a)
|
767,257
|
1,789,303
|
||||||
|
Research and development
|
128,044
|
250,180
|
||||||
|
Sales and marketing
|
3,800
|
282,867
|
||||||
|
Total Operating expenses
|
2,835,504
|
3,747,030
|
||||||
|
|
||||||||
|
LOSS BEFORE OTHER INCOME (EXPENSE)
|
(2,835,504
|
)
|
(3,734,338
|
)
|
||||
|
|
||||||||
|
OTHER (EXPENSE) INCOME
|
||||||||
|
Interest expenses
|
(218,316
|
)
|
(12,871
|
)
|
||||
|
Loss on settlement of related party notes payable
|
(331,912
|
)
|
-
|
|||||
|
Other income
|
392
|
-
|
||||||
|
Loss on disposition of fixed assets
|
-
|
(4,981
|
)
|
|||||
|
Change in fair value of warrants
|
-
|
3,357,149
|
||||||
|
Change in fair value of embedded derivative liability
|
-
|
698,303
|
||||||
|
Fair value of warrants in excess of consideration for convertible preferred stock
|
-
|
(1,949,517
|
)
|
|||||
|
|
(549,836
|
)
|
2,088,083
|
|||||
|
|
||||||||
|
NET LOSS
|
$
|
(3,385,340
|
)
|
$
|
(1,646,255
|
)
|
||
|
|
||||||||
|
Deemed dividend on convertible preferred shares
|
(596,878
|
)
|
-
|
|||||
|
|
||||||||
|
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS
|
$
|
(3,982,218
|
)
|
$
|
(1,646,255
|
)
|
||
|
|
||||||||
|
LOSS PER SHARE
|
||||||||
|
BASIC
|
$
|
(0.14
|
)
|
$
|
(0.24
|
)
|
||
|
DILUTED
|
$
|
(0.14
|
)
|
$
|
(0.24
|
)
|
||
|
|
||||||||
|
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING
|
||||||||
|
BASIC
|
28,244,361
|
6,860,955
|
||||||
|
DILUTED
|
28,244,361
|
6,860,955
|
||||||
| (a) |
Includes share based compensation of $1,800,181 and $1,405,877 for the years ended December 31, 2017 and 2016, respectively.
|
|
Series A
|
Series B
|
Series C
|
Series D
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Convertible
|
Convertible
|
Convertible
|
Convertible
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Preferred
|
Preferred
|
Preferred
|
Preferred
|
Common
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stock
|
Stock
|
Stock
|
Stock
|
Stock
|
Additional
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Number of
|
Number of
|
Number of
|
Number of
|
Number of
|
Paid-In
|
Treasury
|
Deferred
|
Accumulated
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Shares
|
Amount
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Stock
|
Compensation
|
Deficit
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2015
|
441,938
|
$
|
442
|
1.00
|
$
|
-
|
-
|
-
|
5,977,030
|
$
|
5,977
|
$
|
39,779,414
|
$
|
(113,389
|
)
|
$
|
(1,842,334
|
)
|
$
|
(39,998,290
|
)
|
$
|
(2,168,180
|
)
|
|||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Conversion of Series A Convertible Preferred Stock
|
(44,160
|
)
|
(44
|
)
|
-
|
-
|
-
|
-
|
883,200
|
883
|
(839
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||||||||||||||
|
Conversion of Series B Convertible Preferred Stock
|
(0.08
|
)
|
-
|
-
|
-
|
647,983
|
675
|
(675
|
)
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Sale of Series C Convertible Preferred Stock
|
3,087,500
|
3,088
|
-
|
1,231,912
|
-
|
-
|
-
|
-
|
-
|
1,235,000
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stock issuance costs
|
(17,500
|
)
|
-
|
-
|
-
|
-
|
-
|
(17,500
|
)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Conversion of Series C Convertible Preferred Stock
|
(1,175,000
|
)
|
(1,175
|
)
|
166,750
|
167
|
1,175,000
|
1,175
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Stock on embedded derivative liability
|
350,500
|
350,500
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sale of Series D Convertible Preferred Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
66,533
|
-
|
-
|
-
|
66,700
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
Deemed dividend distribution
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,277,521
|
)
|
-
|
-
|
-
|
(1,277,521
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Issuance of stock for services
|
-
|
-
|
-
|
-
|
-
|
-
|
32,983
|
33
|
20,742
|
-
|
-
|
-
|
20,775
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Issuance of restricted stock for services
|
-
|
-
|
-
|
-
|
-
|
-
|
40,000
|
40
|
(40
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Forfeiture of restricted stock units
|
-
|
-
|
-
|
-
|
-
|
-
|
(452,500
|
)
|
(452
|
(1,069,256
|
)
|
-
|
1,069,708
|
-
|
-
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Warrants issued in conjunction with notes payable
|
-
|
-
|
-
|
-
|
-
|
-
|
69,500
|
-
|
-
|
-
|
69,500
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
Fair value of stock options and warrants
|
-
|
-
|
1,405,877
|
-
|
-
|
-
|
1,405,877
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Decrease in fair value of restricted stock units
|
-
|
-
|
(89,375
|
)
|
-
|
89,375
|
-
|
-
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Amortization of deferred compensation
|
-
|
-
|
-
|
-
|
683,251
|
-
|
683,251
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net loss
|
-
|
-
|
-
|
(1,646,255
|
)
|
(1,646,255
|
)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2016
|
397,778
|
398
|
0.92
|
1,912,500
|
1,913
|
166,750
|
167
|
8,330,696
|
8,331
|
40,469,272
|
(113,389
|
)
|
(41,644,545
|
)
|
(1,277,853
|
)
|
||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative adjustment related to change in accounting principle (Note 1, Change in Accounting Principle)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
11,924,665
|
-
|
(11,301,203
|
)
|
623,462
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Adjusted balance at January 1, 2017
|
397,778
|
398
|
0.92
|
-
|
1,912,500
|
1,913
|
166,750
|
167
|
8,330,696
|
8,331
|
52,393,937
|
(113,389
|
)
|
-
|
(52,945,748
|
)
|
(654,391
|
)
|
||||||||||||||||||||||||||||||||||||||||||
|
Conversion of Series A Convertible Preferred Stock
|
(73,000
|
)
|
(73
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
1,460,000
|
1,460
|
(1,387
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||||||||||||
|
Conversion of Series C Convertible Preferred Stock
|
-
|
-
|
-
|
(1,912,500
|
)
|
(1,913
|
)
|
-
|
-
|
4,767,858
|
4,768
|
(2,855
|
)
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||||||||||||||
|
Conversion Preferred C - Warrants
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
6,175,000
|
6,175
|
(6,175
|
)
|
-
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Conversion of Series D Convertible Preferred Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
(166,750
|
)
|
(167
|
)
|
496,429
|
496
|
(329
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||||||||||||
|
Conversion Preferred D - Warrants
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,985,716
|
1,986
|
(1,986
|
)
|
-
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Sale of common stock
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
19,451,575
|
19,452
|
1,340,798
|
-
|
-
|
-
|
1,360,250
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Sale of common stock - Past issuances
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
503,432
|
503
|
(503
|
)
|
-
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Stock Based Compensation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,050,372
|
2,050
|
137,758
|
-
|
139,808
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Stock issuance costs
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(32,325
|
)
|
-
|
-
|
-
|
(32,325
|
)
|
||||||||||||||||||||||||||||||||||||||||||||
|
Conversion of related party notes payable and accrued
interest into common stock |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4,402,079
|
4,402
|
601,133
|
-
|
-
|
-
|
605,535
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Discount on warrants issued in conjunction with
related party notes payable |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
113,586
|
-
|
-
|
-
|
113,586
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Fair value of stock option
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,295,741
|
-
|
-
|
-
|
1,295,741
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Restricted Stock
units and
awards
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,175,000
|
2,175
|
64,650
|
-
|
-
|
-
|
66,825
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Deemed dividend distribution on issuance of common
stock for conversion of Series C and Series D |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(596,878
|
)
|
(596,878
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Accretion of deemed dividend distribution on issuance
of common stock for conversion of Series C and Series D |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
596,878
|
596,878
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Common stock and warrants issued for services
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,725,175
|
1,724
|
296,083
|
297,807
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,385,340
|
)
|
(3,385,340
|
)
|
|||||||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2017
|
324,778
|
$
|
325
|
0.92
|
$
|
-
|
-
|
$
|
-
|
-
|
$
|
-
|
53,523,332
|
$
|
53,522
|
$
|
56,198,126
|
$
|
(113,389
|
)
|
$
|
(56,331,088
|
)
|
$
|
(192,504
|
)
|
||||||||||||||||||||||||||||||||||
|
|
Year Ended
|
|||||||
|
|
December 31, 2017
|
December 31, 2016
|
||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
|
Net loss
|
$
|
(3,385,340
|
)
|
$
|
(1,646,255
|
)
|
||
|
Adjustments to reconcile net loss to net cash used in
|
||||||||
|
operating activities:
|
||||||||
|
Loss on sale of fixed assets
|
-
|
4,980
|
||||||
|
Stock based compensation
|
139,808
|
-
|
||||||
|
Fair value of options issued in exchange for services
|
1,295,741
|
1,405,877
|
||||||
|
Fair value of restricted stock
units and awards
issued in exchange for services
|
66,825
|
-
|
||||||
|
Common stock and warrants issued for services
|
297,807
|
20,775
|
||||||
|
Accretion of discount on notes payable
|
-
|
8,569
|
||||||
|
Amortization of debt discount
|
174,517
|
|||||||
|
Interest rolled into principal
|
30,000
|
|||||||
|
Loss on conversion of related party notes payable and accrued interest
|
331,912
|
-
|
||||||
|
Change in fair value of warrant liability
|
-
|
(1,407,631
|
)
|
|||||
|
Change in fair value of embedded derivative liability
|
(698,303
|
)
|
||||||
|
Amortization and depreciation
|
43,095
|
30,199
|
||||||
|
Amortization of deferred compensation
|
-
|
683,251
|
||||||
|
Series B Preferred Stock issue for licensing fees
|
-
|
-
|
||||||
|
(Increase) decrease in assets
|
||||||||
|
Accounts receivable
|
-
|
-
|
||||||
|
Inventory
|
17,093
|
11,594
|
||||||
|
Prepaid expenses and other current assets
|
(9,243
|
)
|
(9,425
|
)
|
||||
|
Increase in liabilities
|
||||||||
|
Accounts payable and accrued expenses
|
61,867
|
251,661
|
||||||
|
Net cash used in operating activities
|
(935,918
|
)
|
(1,344,708
|
)
|
||||
|
|
||||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
|
Purchase of Patents
|
(2,650
|
)
|
-
|
|||||
|
|
-
|
-
|
||||||
|
Net cash provided by investing activities
|
(2,650
|
)
|
-
|
|||||
|
|
||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
|
Proceeds from issuance of notes payable
|
79,000
|
|||||||
|
Proceeds from issuance of related party notes payable
|
281,000
|
-
|
||||||
|
Proceeds from sale of Series C Convertible Preferred Stock
|
1,235,000
|
|||||||
|
Stock issuance costs
|
(17,500
|
)
|
||||||
|
Proceeds from sale of Series D Convertible Preferred Stock
|
66,700
|
|||||||
|
Proceeds from sale of common stock
|
1,327,925
|
-
|
||||||
|
Net cash provided by financing activities
|
1,608,925
|
1,363,200
|
||||||
|
|
||||||||
|
NET INCREASE IN CASH AND
|
||||||||
|
CASH EQUIVALENTS
|
670,357
|
18,492
|
||||||
|
|
||||||||
|
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
|
22,644
|
4,152
|
||||||
|
|
||||||||
|
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
$
|
693,001
|
$
|
22,644
|
||||
|
|
||||||||
|
|
||||||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
||||||||
|
Cash paid during the year for:
|
||||||||
|
Interest
|
$
|
-
|
$
|
-
|
||||
|
Income taxes
|
$
|
-
|
$
|
-
|
||||
|
|
||||||||
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
|
||||||||
|
|
||||||||
|
Cumulative effect of adoption of ASU 2017-11
|
$
|
623,462
|
$
|
-
|
||||
|
Series A Convertible Preferred Stock converted to common stock
|
$
|
1,460
|
$
|
883
|
||||
|
Series B Convertible Preferred Stock converted to common stock
|
$
|
-
|
$
|
675
|
||||
|
Series C Convertible Preferred Stock converted to common stock
|
$
|
4,768
|
$
|
1,175
|
||||
|
Series D Convertible Preferred Stock converted to common stock
|
$
|
496
|
$
|
-
|
||||
|
Conversion Preferred C - warrants into common stock
|
$
|
6,175
|
$
|
-
|
||||
|
Conversion Preferred D - warrants into common stock
|
$
|
1,986
|
$
|
-
|
||||
|
Security deposit offset against accounts payable
|
$
|
-
|
$
|
37,197
|
||||
|
Accretion of discount on preferred stock as deemed dividend distribution
|
$
|
-
|
$
|
1,277,521
|
||||
|
Deemed dividend distribution on issuance of common stock for conversion of Series C and Series D
|
$
|
596,878
|
$
|
-
|
||||
|
Revaluation of restricted stock units additional paid in capital and deferred compensation
|
$
|
-
|
$
|
89,375
|
||||
|
Forfeited restricted common stock
|
$
|
-
|
$
|
1,069,708
|
||||
|
Revaluation of embedded derivative liability upon conversion of Series C Convertible Preferred Stock
|
$
|
-
|
$
|
350,500
|
||||
|
Conversion of related party notes payable and accrued interest into common stock
|
$
|
273,623
|
$
|
-
|
||||
|
Common stock payable for conversion of related party notes payable and accrued interest
|
$
|
122,478
|
$
|
-
|
||||
|
Warrants issued as discount to related party notes payable
|
$
|
113,586
|
$
|
69,500
|
||||
|
Sale of common stock - past issuances
|
$
|
503
|
$
|
-
|
||||
|
Balance Sheet Accounts Impacted by
Warrants and Embedded Derivative Liability |
As
Previously Reported December 31, 2016 |
Cumulative
Effect Adjustment at the Beginning of 2017 |
Reported after the
Effect of a Change in Accounting Principle at the Beginning of 2017 |
|||||||||
|
Embedded derivative liability
|
$
|
228,718
|
$
|
(228,718
|
)
|
$
|
-
|
|||||
|
Warrant liability
|
394,744
|
(394,744
|
)
|
-
|
||||||||
|
Additional paid in capital
|
40,469,272
|
11,924,665
|
52,393,937
|
|||||||||
|
Accumulated deficit
|
(41,644,545
|
)
|
(11,301,203
|
)
|
(52,945,748
|
)
|
||||||
| • |
ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”
|
| • |
ASU 2016-08 “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net).”
|
| • |
ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing.”
|
| • |
ASU 2016-11, “Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF (Emerging Issue Task Force) Meeting.”
|
| • |
ASU 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.”
|
| • |
ASU 2016-20, “Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers.”
|
| • |
ASU 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840) and Leases (Topic 842). Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.”
|
|
Year ended December 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
Software, furniture and fixtures
|
$
|
200,000
|
$
|
200,000
|
||||
|
Equipment
|
3,223
|
3,223
|
||||||
|
Total
|
203,223
|
203,223
|
||||||
|
Less: accumulated depreciation
|
(203,223
|
)
|
(203,223
|
)
|
||||
|
Balance
|
$
|
-
|
$
|
-
|
||||
|
Year Ended December 31
|
||||||||
|
US
|
2017
|
2016
|
||||||
|
Income before income taxes
|
$
|
(3,385
|
)
|
$
|
(1,646
|
)
|
||
|
Taxes under statutory US tax rates
|
(1,202
|
)
|
(576
|
)
|
||||
|
Increase (decrease) in taxes resulting from:
|
||||||||
|
Increase (decrease) in valuation allowance
|
1,346
|
1,391
|
||||||
|
Foreign tax rate differential
|
||||||||
|
Non-deductible changes in derivative liability and share based transactions
|
1
|
(716
|
)
|
|||||
|
State taxes
|
(145
|
)
|
(99
|
)
|
||||
|
Income tax expense
|
$
|
-
|
|
$
|
-
|
|
||
|
December 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
US
|
||||||||
|
Net operating loss
|
$
|
7,035
|
$
|
13,263
|
||||
|
Share based compensation
|
1,800
|
5,165
|
||||||
|
Reserves and accruals
|
12
|
|||||||
|
Gross deferred tax assets
|
8,835
|
18,440
|
||||||
|
Less valuation allowance
|
(8,835
|
)
|
(18,275
|
)
|
||||
|
Total deferred tax assets
|
-
|
165
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Amortization of acquired intangibles
|
-
|
(165
|
)
|
|||||
|
Total deferred tax liabilities
|
-
|
(165
|
)
|
|||||
|
Net deferred tax assets / (liabilities)
|
$
|
-
|
$
|
-
|
|
|||
|
Year ended December 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
Series A notes payable; interest at 8% per annum; principal and
accrued interest due at maturity in October 2011 (past due) |
$
|
50,000
|
$
|
50,000
|
||||
|
Notes payable; interest rate at 5% per annum; principal and
accrued interest due at maturity on June 30, 2017 |
-
|
79,000
|
||||||
|
Less: unamortized discount
|
-
|
(60,931
|
)
|
|||||
|
Net
|
50,000
|
68,069
|
||||||
|
Less: current portion
|
(50,000
|
)
|
(68,069
|
)
|
||||
|
Balance
|
$
|
-
|
$
|
-
|
||||
|
December 31, 2017
|
December 31, 2016
|
|||||||||||||||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||||||||||||||
|
Embedded derivative liability related
to beneficial conversion option |
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
228,718
|
$
|
228,718
|
||||||||||||||||
|
Derivative liability related to fair
value of warrants |
-
|
-
|
-
|
-
|
-
|
-
|
394,744
|
394,744
|
||||||||||||||||||||||||
|
Total
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
623,462
|
$
|
623,462
|
||||||||||||||||
|
Total
|
||||
|
Balance, January 1, 2016
|
$
|
1,802,375
|
||
|
Series C embedded derivative fair value, February 2016
|
1,235,000
|
|||
|
Effect of conversion of Series C Preferred Stock on embedded derivative liability
|
(350,500
|
)
|
||
|
Series C warrant liability fair value, February 2016
|
1,767,576
|
|||
|
Series D embedded derivative fair value, October 2016
|
42,521
|
|||
|
Series D warrant liability fair value, October 2016
|
181,942
|
|||
|
Change in fair value of derivative liabilities
|
(4,055,452
|
)
|
||
|
Balance, December 31, 2016
|
623,462
|
|||
|
Cumulative adjustments related to change in accounting principle, January 1, 2017
|
(623,462
|
)
|
||
|
Balance, December 31, 2017
|
$
|
-
|
||
|
December 31, 2017
|
December 31, 2016
|
|||||||
|
Closing trade price of Common Stock
|
$
|
-
|
$
|
0.11
|
||||
|
Effective Series C Preferred Stock Conversion Price
|
-
|
-
|
||||||
|
Effective Series D Preferred Stock Conversion Price
|
-
|
-
|
||||||
|
Intrinsic value of conversion option per share
|
$
|
-
|
$
|
0.11
|
||||
|
December 31, 2017
|
December 31, 2016
|
|||||||
|
Annual Dividend Yield
|
-
|
0.0%
|
|
|||||
|
Expected Life (Years)
|
-
|
1.5 – 2.8
|
||||||
|
Risk-Free Interest Rate
|
-
|
1.2% - 1.5%
|
|
|||||
|
Expected Volatility
|
-
|
215.8% - 234.1%
|
|
|||||
|
|
|
2017
|
|
|
2016
|
|
||
|
|
|
|
|
|
|
|
||
|
Risk Free Interest Rate
|
|
|
1.90%
|
|
|
|
2.41%
|
|
|
Expected Volatility
|
|
|
199.20%
|
|
|
|
310.0%
|
|
|
Expected Life (in years)
|
|
|
5.0
|
|
|
|
9.4
|
|
|
Dividend Yield
|
|
|
0%
|
|
|
|
0%
|
|
|
Weighted average estimated fair value of
|
|
|
|
|
|
|
|
|
|
options during the period
|
|
$
|
0.07
|
|
|
$
|
0.18
|
|
|
|
Options Outstanding
|
|||||||||||||||
|
|
Weighted -
|
|||||||||||||||
|
|
Average
|
|||||||||||||||
|
|
Remaining
|
Aggregate
|
||||||||||||||
|
|
Weighted-
|
Contractual
|
Intrinsic
|
|||||||||||||
|
|
Number of
|
Average
|
Term
|
Value
|
||||||||||||
|
|
Shares
|
Exercise Price
|
(in years)
|
(1)
|
||||||||||||
|
|
||||||||||||||||
|
Balance as of December 31, 2015
|
2,157,353
|
$
|
1.80
|
|||||||||||||
|
|
||||||||||||||||
|
Granted
|
2,490,000
|
0.24
|
||||||||||||||
|
Exercised
|
(7,843
|
)
|
0.05
|
|||||||||||||
|
Forfeited/cancelled
|
(308,235
|
)
|
(0.06
|
)
|
||||||||||||
|
|
||||||||||||||||
|
Balance December 31, 2016
|
3,282,647
|
$
|
0.52
|
|||||||||||||
|
|
||||||||||||||||
|
Granted
|
19,950,000
|
$
|
0.07
|
|||||||||||||
|
Forfeited/cancelled
|
(1,219,117
|
)
|
$
|
0.48
|
||||||||||||
|
|
||||||||||||||||
|
Balance December 31, 2017
|
22,013,529
|
$
|
0.11
|
4.8
|
||||||||||||
|
|
||||||||||||||||
|
Exercisable at December 31, 2017
|
19,346,862
|
$
|
0.12
|
4.8
|
$
|
3,480,567
|
||||||||||
|
|
||||||||||||||||
| (1) |
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. During the years ended December 31, 2017 and 2016, the aggregate intrinsic value of options exercised under the Company’s stock option plans was $3,480,567 and less than $1,000, respectively.
|
|
|
Unvested Options
|
|||||||
|
|
Weighted -
|
|||||||
|
|
Average
|
|||||||
|
|
Grant
|
|||||||
|
|
Number of Unvested
|
Date Exercise Price
|
||||||
|
|
Options
|
|||||||
|
Balance December 31, 2016
|
-
|
$
|
-
|
|||||
|
|
||||||||
|
Granted
|
19,950,000
|
0.07
|
||||||
|
|
||||||||
|
Vested
|
(16,833,333
|
)
|
0.07
|
|||||
|
|
||||||||
|
Cancelled/forfeited/expired
|
(450,000
|
)
|
0.08
|
|||||
|
|
||||||||
|
Balance December 31, 2017
|
2,666,667
|
$
|
0.06
|
|||||
|
|
Warrants Outstanding
|
|||||||||||||||
|
|
Number of
Shares |
Weighted-
Average
Exercise
Price
|
Weighted -
Average
Remaining
Contractual
Term
in years)
|
Aggregate
Intrinsic
Value
(in 000's)
(1) |
||||||||||||
|
Balance, December 31, 2015
|
1,414,893
|
$
|
9.67
|
|
|
|||||||||||
|
Expired
|
(2,941
|
)
|
0.85
|
|
|
|||||||||||
|
Granted
|
7,804,500
|
0.39
|
|
|
||||||||||||
|
|
|
|||||||||||||||
|
Balance, December 31, 2016
|
9,216,452
|
$
|
1.82
|
|
|
|||||||||||
|
Issued
|
33,080,629
|
0.20
|
|
|||||||||||||
|
Cancelled/Forfeited
|
(10,004,500
|
)
|
0.40
|
|
|
|||||||||||
|
|
|
|
||||||||||||||
|
Balance, December 31, 2017
|
32,292,580
|
$
|
0.30
|
4.30
|
||||||||||||
|
|
||||||||||||||||
|
Exercisable at December 31, 2017
|
32,292,580
|
$
|
0.30
|
4.30
|
$
|
3,345
|
||||||||||
| (1) |
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.27 for our common stock on December 31, 2017.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|